Biochemiczna ocena skuteczności leczenia pacjentów z akromegalią
Journal Title: Folia Medica Lodziensia - Year 2014, Vol 41, Issue 2
Abstract
Introduction: The main treatment for acromegaly is the surgical removal of the tumour. Pharmacotherapy, usually with somatostatin analogues (SSA), is used as the preliminary and/or complementary therapy. In the diagnosis of acromegaly as well as in the evaluation of treatment effectiveness laboratory tests are essential – the serum level of growth hormone (GH) in the oral glucose tolerance test (OGTT) and the serum concentration of insulin-like growth factor 1 (IGF-1). The aim of our study was to evaluate the effectiveness of the treatment of patients with acromegaly based on biochemical criteria for cure. Material and methods: The study group consisted of 40 patients aged 25 - 83, hospitalized in the Department of Endocrinology, Medical University of Lodz in the years 2003-2010. The concentration of GH and IGF-1 were determined by enzyme-amplified chemiluminescent immunoassay (EACLIA) on the IMMULITE 1000 analyzer (Siemens). As the criteria of acromegaly cure we assumed the normalization of serum IGF-1 and GH levels after oral glucose administration of < 1 ng/mL. Results: The cure of acromegaly was achieved in 25 of 40 patients (63%). In 14 patients, the normalization of IGF-1 and GH was obtained as a result of surgery, 11 patients achieved normal laboratory parameters after complemantary treatment - five after the treatment with SSA, four after radiotherapy, and two after both pharmaco - and radiotherapy. Fifteen patients from the study group have not been cured - in 13 of them the complementary therapy with SSA was used. Most of them (75%) were operated due to the pituitary macroadenoma. In 11 persons both GH and IGF-1 concentrations exceeded the limits of the reference values. The effectiveness of the operation was higher in patients treated with SSA - among 21 patients treated with SSA before the surgery, only five did not achieve the normalization of GH and/or IGF-1. Conclusions: The evaluation of GH and IGF-1 concentrations with the connection of the magnetic resonance imaging of the pituitary allow to determine the effects of acromegaly treatment. In the majority of patients after the surgical removal of pituitary adenoma, complementary therapy, mainly pharmacological with somatostatin analogues is necessary, and some patients require reoperation and / or radiotherapy. In addition, the preoperative administration of somatostatin analogues greatly increases the effectiveness of the treatment of acromegaly.
Authors and Affiliations
Julita Fuss-Chmielewska, Karolina Beda-Maluga, Hanna Pisarek, Katarzyna Winczyk, Aleksandra Rosiak
Keywords
Related Articles
- EP ID EP169069
- DOI -
- Views 89
- Downloads 0
Rola mesalazyny w chemoprewencji raka jelita grubego
Colorectal cancer (CRC) is the fourth most commonly diagnosed cancer in females and the third in males. Every year there are more than a million new cases of colorectal cancer and more than six hundred thousand patients...
Analiza częstości występowania polimorfizmu C421A genu ABCG2 w przypadkach raków żołądka w regionie łódzkim
Introduction: In the present thesis the association between the variants of C421A polymorphism of ABCG2 gene and the risk of gastric cancer development were searched. The occurrence of polymorphic variant 421 C > A leads...
Przydatność kliniczna i diagnostyczna oznaczeń D–dimeru w różnych stanach chorobowych
There are many methods dedicated to assessing D–dimer. They are divided into two categories: qualitative and quantitative methods. All the methods are based on immunochemical reaction with the use of monoclonal antibodie...
Czy „cichy” polimorfizm pojedynczego nukleotydu (SNP) C1236T genu ABCB1 jest związany z predyspozycją do rozwoju depresji i skutecznością jej leczenia? - badanie wstępne
Introduction: According to the World Health Organization about 350 million people around the world are affected by depression. Despite the high prevalence of this disease the mechanism of depression origination as well a...
Ocena profilu lipidowego u pacjentów aglomeracji łódzkiej leczonych statynami
Introduction: In more than the half of the population in Europe, including Poland, blood lipid profile is abnormal. These abnormalities are: high total cholesterol (TCh) levels (> 5.0 mmol/L or 190 mg/dL), often accompan...